Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Tuberculosis, Multidrug-Resistant, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Lymphoma, Non-Hodgkin;Hodgkin Disease, Date of authorisation: 25/10/2012, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Otezla, apremilast, Arthritis, Psoriatic;Psoriasis, Date of authorisation: 15/01/2015, Revision: 21, Status: Authorised

COVID-19 vaccines - Safety update: 14 July 2022

Human medicines European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva, COVID-19 vaccine (inactivated, adjuvanted, adsorbed), Date of authorisation: 24/06/2022, Revision: 6, Status: Withdrawn

EU medicines agencies reflect on lessons learned from COVID-19

COVID-19 lessons learned: Joint report on the response to the public health emergency

Human medicines European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva, COVID-19 vaccine (inactivated, adjuvanted, adsorbed), COVID-19 virus infection, Date of authorisation: 24/06/2022, Revision: 6, Status: Withdrawn

Analapril / nitrendipine : List of nationally authorised medicinal products - PSUSA/00001213/202301

Drospirenone : List of nationally authorised medicinal products - PSUSA/00010853/202211